Age-dependent axonal degeneration in an Alzheimer mouse model

Neurobiology of Aging

Volumn 28, Issue 11, 2007, Pages 1689-1699

  Wirths, Oliver ^a   Weis, Joachim ^b   Kayed, Rakez ^c   Saido, Takaomi C ^d   Bayer, Thomas A ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b RWTH AACHEN UNIVERSITY   (Germany)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

Author keywords

Alzheimer; Amyloid; Axonal degeneration; Axonal transport; Axonopathy; Intraneuronal A ; Transgenic mice

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; MYELIN; THIOFLAVINE;

AGING; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; BRAIN CORTEX; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NERVE FIBER; NERVE FIBER DEGENERATION; NEUROPATHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPINAL CORD; TRANSGENIC MOUSE; TUMOR SPHEROID; ULTRASTRUCTURE;

ADULT; AGE FACTORS; AGING; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; AXONAL TRANSPORT; AXONS; DISEASE MODELS, ANIMAL; HUMANS; MALE; MICE; MICE, TRANSGENIC; NERVE DEGENERATION;

EID: 34548553576     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2006.07.021     Document Type: Article

References (43)

1. Arendash G.W., Gordon M.N., Diamond D.M., Austin L.A., Hatcher J.M., Jantzen P., et al. Behavioral assessment of Alzheimer's transgenic mice following long-term Abeta vaccination: task specificity and correlations between Abeta deposition and spatial memory. DNA Cell Biol 20 11 (2001) 737-744
2. Bayer T.A., Wirths O., Majtenyi K., Hartmann T., Multhaup G., Beyreuther K., et al. Key factors in Alzheimer's disease: β-amyloid precursor protein processing, metabolism and intraneuronal transport. Brain Pathol 11 (2001) 1-11
3. Calingasan N.Y., Chen J., Kiaei M., and Beal M.F. Beta-amyloid 42 accumulation in the lumbar spinal cord motor neurons of amyotrophic lateral sclerosis patients. Neurobiol Dis 19 1-2 (2005) 340-347
4. Casas C., Sergeant N., Itier J.M., Blanchard V., Wirths O., van der Kolk N., et al. Massive CA1/2 neuronal loss with intraneuronal and N-terminal truncated Abeta42 accumulation in a novel Alzheimer transgenic model. Am J Pathol 165 4 (2004) 1289-1300
5. Cataldo A.M., Petanceska S., Terio N.B., Peterhoff C.M., Durham R., Mercken M., et al. Abeta localization in abnormal endosomes: association with earliest Abeta elevations in AD and Down syndrome. Neurobiol Aging 25 10 (2004) 1263-1272
6. Coleman M. Axon degeneration mechanisms: commonality amid diversity. Nat Rev Neurosci 14 (2005) 14
7. D'Andrea M.R., Nagele R.G., Wang H.Y., Peterson P.A., and Lee D.H. Evidence that neurones accumulating amyloid can undergo lysis to form amyloid plaques in Alzheimer's disease. Histopathology 38 2 (2001) 120-134
8. Geddes J.W., Tekirian T.L., and Mattson M.P. N-terminus truncated beta-amyloid peptides and C-terminus truncated secreted forms of amyloid precursor protein: distinct roles in the pathogenesis of Alzheimer's disease. Neurobiol Aging 20 1 (1999) 75-79 discussion 87
9. Gouras G.K., Tsai J., Naslund J., Vincent B., Edgar M., Checler F., et al. Intraneuronal Abeta42 accumulation in human brain. Am J Pathol 156 January (1) (2000) 15-20
10. Gyure K.A., Durham R., Stewart W.F., Smialek J.E., and Troncoso J.C. Intraneuronal abeta-amyloid precedes development of amyloid plaques in Down syndrome. Arch Pathol Lab Med 125 4 (2001) 489-492
11. He W., and Barrow C.J. The A beta 3-pyroglutamyl and 11-pyroglutamyl peptides found in senile plaque have greater beta-sheet forming and aggregation propensities in vitro than full-length A beta. Biochemistry 38 33 (1999) 10871-10877
12. Kamal A., Almenar-Queralt A., LeBlanc J.F., Roberts E.A., and Goldstein L.S. Kinesin-mediated axonal transport of a membrane compartment containing beta-secretase and presenilin-1 requires APP. Nature 414 6864 (2001) 643-648
13. Kamal A., Stokin G.B., Yang Z., Xia C.H., and Goldstein L.S. Axonal transport of amyloid precursor protein is mediated by direct binding to the kinesin light chain subunit of kinesin-I. Neuron 28 2 (2000) 449-459
14. Kayed R., Head E., Sarsoza F., Milton S.C., Thompson J.L., Necula M., et al. Probing fibril formation in vitro and in vivo using a fibril-specific antibody: common pathways of fibril formation (2005), Society of Neuroscience Abstract No. 422.20
15. Koo E.H., Sisodia S.S., Archer D.R., Martin L.J., Weidemann A., Beyreuther K., et al. Precursor of amyloid protein in Alzheimer disease undergoes fast anterograde axonal transport. Proc Natl Acad Sci USA 87 4 (1990) 1561-1565
16. Lazarov O., Lee M., Peterson D.A., and Sisodia S.S. Evidence that synaptically released beta-amyloid accumulates as extracellular deposits in the hippocampus of transgenic mice. J Neurosci 22 22 (2002) 9785-9793
17. Lazarov O., Morfini G.A., Lee E.B., Farah M.H., Szodorai A., DeBoer S.R., et al. Axonal transport, amyloid precursor protein, kinesin-1, and the processing apparatus: revisited. J Neurosci 25 9 (2005) 2386-2395
18. Mori C., Spooner E.T., Wisniewsk K.E., Wisniewski T.M., Yamaguch H., Saido T.C., et al. Intraneuronal Abeta42 accumulation in Down syndrome brain. Amyloid 9 2 (2002) 88-102
19. Munoz D.G., Greene C., Perl D.P., and Selkoe D.J. Accumulation of phosphorylated neurofilaments in anterior horn motoneurons of amyotrophic lateral sclerosis patients. J Neuropathol Exp Neurol 47 1 (1988) 9-18
20. Oddo S., Caccamo A., Shepherd J.D., Murphy M.P., Golde T.E., Kayed R., et al. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 39 3 (2003) 409-421
21. Ogomori K., Kitamoto T., Tateishi J., Sato Y., Suetsugu M., and Abe M. Beta-protein amyloid is widely distributed in the central nervous system of patients with Alzheimer's disease. Am J Pathol 134 2 (1989) 243-251
22. O'Keeffe S.T., Kazeem H., Philpott R.M., Playfer J.R., Gosney M., and Lye M. Gait disturbance in Alzheimer's disease: a clinical study. Age Ageing 25 4 (1996) 313-316
23. Piccini A., Russo C., Gliozzi A., Relini A., Vitali A., Borghi R., et al. Beta-amyloid is different in normal aging and in Alzheimer disease. J Biol Chem 280 40 (2005) 34186-34192
24. Pigino G., Morfini G., Pelsman A., Mattson M.P., Brady S.T., and Busciglio J. Alzheimer's presenilin 1 mutations impair kinesin-based axonal transport. J Neurosci 23 11 (2003) 4499-4508
25. Probst A., Gotz J., Wiederhold K.H., Tolnay M., Mistl C., Jaton A.L., et al. Axonopathy and amyotrophy in mice transgenic for human four-repeat Tau protein. Acta Neuropathol (Berl) 99 5 (2000) 469-481
26. Ross C.A., and Poirier M.A. Protein aggregation and neurodegenerative disease. Nat Med 10 Suppl. (2004) S10-S17
27. Rouleau G.A., Clark A.W., Rooke K., Pramatarova A., Krizus A., Suchowersky O., et al. SOD1 mutation is associated with accumulation of neurofilaments in amyotrophic lateral sclerosis. Ann Neurol 39 1 (1996) 128-131
28. Russo C., Saido T.C., DeBusk L.M., Tabaton M., Gambetti P., and Teller J.K. Heterogeneity of water-soluble amyloid beta-peptide in Alzheimer's disease and Down's syndrome brains. FEBS Lett 409 3 (1997) 411-416
29. Russo C., Violani E., Salis S., Venezia V., Dolcini V., Damonte G., et al. Pyroglutamate-modified amyloid beta-peptides - AbetaN3(pE) - strongly affect cultured neuron and astrocyte survival. J Neurochem 82 6 (2002) 1480-1489
30. Saido T.C., Iwatsubo T., Mann D.M., Shimada H., Ihara Y., and Kawashima S. Dominant and differential deposition of distinct beta-amyloid peptide species, A beta N3(pE), in senile plaques. Neuron 14 2 (1995) 457-466
31. Saito Y., and Murayama S. Expression of Tau immunoreactivity in the spinal motor neurons of Alzheimer's disease. Neurology 55 11 (2000) 1727-1729
32. Scarmeas N., Hadjigeorgiou G.M., Papadimitriou A., Dubois B., Sarazin M., Brandt J., et al. Motor signs during the course of Alzheimer disease. Neurology 63 6 (2004) 975-982
33. Schmidt M.L., Zhukareva V., Perl D.P., Sheridan S.K., Schuck T., Lee V.M., et al. Spinal cord neurofibrillary pathology in Alzheimer disease and Guam Parkinsonism-dementia complex. J Neuropathol Exp Neurol 60 11 (2001) 1075-1086
34. Stokin G.B., Lillo C., Falzone T.L., Brusch R.G., Rockenstein E., Mount S.L., et al. Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease. Science 307 5713 (2005) 1282-1288
35. Stone J.R., Okonkwo D.O., Dialo A.O., Rubin D.G., Mutlu L.K., Povlishock J.T., et al. Impaired axonal transport and altered axolemmal permeability occur in distinct populations of damaged axons following traumatic brain injury. Exp Neurol 190 1 (2004) 59-69
36. Takahashi R.H., Almeida C.G., Kearney P.F., Yu F., Lin M.T., Milner T.A., et al. Oligomerization of Alzheimer's beta-amyloid within processes and synapses of cultured neurons and brain. J Neurosci 24 14 (2004) 3592-3599
37. Tesseur I., Van Dorpe J., Bruynseels K., Bronfman F., Sciot R., Van Lommel A., et al. Prominent axonopathy and disruption of axonal transport in transgenic mice expressing human apolipoprotein E4 in neurons of brain and spinal cord. Am J Pathol 157 5 (2000) 1495-1510
38. Weis J., Saxena S., Evangelopoulos M.E., and Kruttgen A. Trophic factors in neurodegenerative disorders. IUBMB Life 55 6 (2003) 353-357
39. Wirths O., Multhaup G., and Bayer T.A. A modified beta-amyloid hypothesis: intraneuronal accumulation of the beta-amyloid peptide-the first step of a fatal cascade. J Neurochem 91 3 (2004) 513-520
40. Wirths O., Multhaup G., Czech C., Blanchard V., Moussaoui S., Tremp G., et al. Intraneuronal Abeta accumulation precedes plaque formation in beta-amyloid precursor protein and presenilin-1 double-transgenic mice. Neurosci Lett 306 1-2 (2001) 116-120
41. Wirths O., Multhaup G., Czech C., Feldmann N., Blanchard V., Tremp G., et al. Intraneuronal APP/A beta trafficking and plaque formation in beta-amyloid precursor protein and presenilin-1 transgenic mice. Brain Pathol 12 3 (2002) 275-286
42. Yagishita S. Morphological investigations on axonal swellings and spheroids in various human diseases. Virchows Arch A Pathol Anat Histol 378 3 (1978) 181-197
43. Zhu X., Moreira P.I., Smith M.A., and Perry G. Alzheimer's disease: an intracellular movement disorder?. Trends Mol Med 11 9 (2005) 391-393